Immunofluorescence and co-localization (Fig 1D) indicated that apoptosis was predominantly restricted to type II AECs, indicating a temporal, spatial and cell-specific link between increased p53 and PAI-1 expression and apoptosis in type II AECs of the lungs of COPD patients. The gene discussed is TP53; the disease is chronic obstructive pulmonary disease.